| 2025-11-10 |
详情>>
股本变动：
变动后总股本25998.29万股
|
| 2025-11-10 |
详情>>
业绩披露：
2025年三季报(累计)每股收益1.51美元,归母净利润3.92亿美元,同比去年增长-48.08%
|
| 2025-11-10 |
详情>>
业绩披露：
2024年年报每股收益3.36美元,归母净利润8.64亿美元,同比去年增长-15.54%
|
| 2025-11-10 |
详情>>
业绩披露：
2022年年报每股收益3.61美元,归母净利润9.17亿美元,同比去年增长-32.12%
|
| 2025-11-10 |
财报披露：
美东时间 2025-11-10 盘前发布财报
|
| 2025-11-07 |
详情>>
内部人交易：
Holzbaur Lynette等共交易6笔
|
| 2025-10-27 |
复牌提示：
2025-10-27 07:09:55 停牌，复牌日期 2025-10-27 07:48:44
|
| 2025-08-06 |
详情>>
业绩披露：
2025年中报每股收益0.90美元,归母净利润2.32亿美元,同比去年增长-41.41%
|
| 2025-05-02 |
详情>>
业绩披露：
2025年一季报每股收益0.34美元,归母净利润8700.00万美元,同比去年增长-56.72%
|
| 2025-04-25 |
股东大会：
将于2025-06-10召开股东大会
会议内容 ▼▲
- 1.Election of the eleven directors named in the accompanying proxy statement to hold office for a one-year term until the 2026 Annual Meeting of Shareholders;
2.Approval, on a non-binding advisory basis, of the compensation of our named executive officers;
3.Approval of an amendment and restatement of the Organon & Co. 2021 Incentive Stock Plan;
4.Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2025;
5.Consider and act upon a shareholder proposal requesting adoption of a director election resignation guideline, if properly presented at the meeting;
6.Consideration of such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2024-11-01 |
详情>>
业绩披露：
2024年三季报(累计)每股收益2.94美元,归母净利润7.55亿美元,同比去年增长58.28%
|
| 2024-08-07 |
详情>>
业绩披露：
2024年中报每股收益1.54美元,归母净利润3.96亿美元,同比去年增长-5.49%
|
| 2024-05-03 |
详情>>
业绩披露：
2024年一季报每股收益0.78美元,归母净利润2.01亿美元,同比去年增长13.56%
|
| 2024-04-25 |
股东大会：
将于2024-06-04召开股东大会
会议内容 ▼▲
- 1.Election of the four Class III directors named in the accompanying proxy statement to hold office for a one-year term until the 2025 Annual Meeting of Shareholders;
2.Approval, on a non-binding advisory basis, of the compensation of our named executive officers;
3.Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2024;
4.Consideration of such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2024-02-26 |
详情>>
业绩披露：
2023年年报每股收益4.01美元,归母净利润10.23亿美元,同比去年增长11.56%
|
| 2023-11-03 |
详情>>
业绩披露：
2023年三季报(累计)每股收益1.87美元,归母净利润4.77亿美元,同比去年增长-41.04%
|
| 2023-04-27 |
股东大会：
将于2023-06-06召开股东大会
会议内容 ▼▲
- 1.Elect the four Class II directors named in the accompanying proxy statement to hold office until the 2025 annual meeting of shareholders;
2.Approve, on a non-binding advisory basis, the compensation of our Named Executive Officers;
3.Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2023;
4.Consider such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2022-04-28 |
股东大会：
将于2022-06-07召开股东大会
会议内容 ▼▲
- 1.Election of Directors
2.Approve, on a Non-Binding Advisory Basis, the Compensation of Organon’s Named Executive Officers
3.Approve, on a Non-Binding Advisory Basis, the Frequency of Future Votes to Approve the Compensation of Organon’s Named Executive Officers
4.Ratify the Appointment of PricewaterhouseCoopers LLP as Organon’s Independent Registered Public Accounting Firm for 2022
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|